Description  Claims  Drawing  Cited references 

WO2016012800A   [0019]  [0019]  [0019]  [0021] 
EP0640619A1   [0091]  [0153]  [0153] 
WO2016012800A1   [0153] 

Nature   [0009] 
Dengue virus sero-cross-reactivity drives antibody-dependent enhancement of infection with Zika virus   [0013] 
Dengue virus antibodies enhance Zika virus infection   [0014] 
Liposomal Co-Entrapment of CD40mAb Induces Enhanced IgG Responses against Bacterial Polysaccharide and Protein   [0079] 
Molecular Cloning: A Laboratory Manual   [0080] 
Oligonucleotide Synthesis   [0080] 
Cell Culture   [0080] 
Methods in Enzymology   [0080] 
Gene Transfer Vectors for Mammalian Cells   [0080] 
Handbook of Experimental Immunology   [0080] 
Current Protocols in Molecular Biology   [0080] 
Current Protocols in Immunology   [0080] 
Signaling by Antibodies... Ann. Rev. Immunol   [0100] 
Methods in Enzymology   [0116] 
J Virol   [0134] 
Emerging Principles for the Therapeutic Exploitation of Glycosylation   [0153] 
he location of asparagine-linked....   [0153] 
A new class of highly potent, broadly neutralizing antibodies isolated from viremic patients infected with dengue virus   [0153] 
Enhancement of therapeutic protein in vivo activities through glycoengineering   [0153] 
Engineering virus-like particles as vaccine platforms   [0153] 
Efficacy and Long-Term Safety of a Dengue Vaccine in Regions of Endemic Disease   [0153] 
Original antigenic sin in dengue   [0153] 
The Double-Edged Sword: How Evolution Can Make or Break a Live-Attenuated Virus Vaccine   [0153] 
Structure of the thermally stable Zika virus   [0153] 
The ''co-delivery'' approach to liposomal vaccines: application to the development of influenza-A and hepatitis-B vaccine candidates   [0153] 
Dengue Virus Antibodies Enhance Zika Virus Infection   [0153] 
Immunogenicity, safety, and tolerability of a recombinant measles-virus-based chikungunya vaccine: a randomised, double-blind, placebo-controlled, active-comparator, first-in-man trial   [0153] 
West Nile Virus Genome with Glycosylated Envelope Protein and Deletion of Alpha Helices 1, 2, and 4 in the Capsid Protein Is Noninfectious and Efficiently Secretes Subviral Particles...   [0153] 
Increased expression of capsid protein in trans enhances production of single-round infectious particles by West Nile virus DNA vaccine candidate   [0153] 
The Zika Pandemic - A Perfect Storm?   [0153] 
The 3.8 A resolution cryo-EM structure of Zika virus   [0153] 
Using Plasmids as DNA Vaccines for Infectious Diseases   [0153] 
Plasmid DNA initiates replication of yellow fever vaccine in vitro and elicits virus-specific immune response in mice   [0153]